{"entity":{"type":"insider","cik":"0001796356","url":"/insider/0001796356","json_url":"/insider/0001796356.json","name":"Column Group IV GP, LP","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":73,"n_filings":26,"first":"2022-01-26","last":"2026-02-09","span_basis":"filed_date"},"name_variants":[{"name":"Column Group IV GP, LP","source":"filing","n_filings":26,"first_seen":"2022-01-26","last_seen":"2026-02-09"}],"transactions":[{"id":5958428,"accession":"0001193125-26-043320","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001193125-26-043320","line_url":"/filing/0001193125-26-043320#line-10","is_derivative":false,"issuer_cik":"0001606074","issuer_name":"Eikon Therapeutics, Inc.","issuer_ticker":"EIKN","issuer_name_source":null,"issuer_url":"/issuer/0001606074","owner_cik":null,"owner_name":"Column Group IV GP, LP; Column Group IV, LP; Column Group IV-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; Kutzkey Tim; Svennilson Peter; TCG Opportunity III GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1437323.0,"shares_display":"1,437,323","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":25871814.0,"total_display":"25,871,814.00","shares_owned_after":4312139.0,"shares_owned_after_display":"4,312,139","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-02-06","filed_date":"2026-02-09","scope":"insider"},{"id":5958425,"accession":"0001193125-26-043320","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001193125-26-043320","line_url":"/filing/0001193125-26-043320#line-9","is_derivative":false,"issuer_cik":"0001606074","issuer_name":"Eikon Therapeutics, Inc.","issuer_ticker":"EIKN","issuer_name_source":null,"issuer_url":"/issuer/0001606074","owner_cik":null,"owner_name":"Column Group IV GP, LP; Column Group IV, LP; Column Group IV-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; Kutzkey Tim; Svennilson Peter; TCG Opportunity III GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":630881.0,"shares_display":"630,881","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":11355858.0,"total_display":"11,355,858.00","shares_owned_after":1319164.0,"shares_owned_after_display":"1,319,164","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-02-06","filed_date":"2026-02-09","scope":"insider"},{"id":5958422,"accession":"0001193125-26-043320","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001193125-26-043320","line_url":"/filing/0001193125-26-043320#line-8","is_derivative":false,"issuer_cik":"0001606074","issuer_name":"Eikon Therapeutics, Inc.","issuer_ticker":"EIKN","issuer_name_source":null,"issuer_url":"/issuer/0001606074","owner_cik":null,"owner_name":"Column Group IV GP, LP; Column Group IV, LP; Column Group IV-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; Kutzkey Tim; Svennilson Peter; TCG Opportunity III GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":49556.0,"shares_display":"49,556","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":892008.0,"total_display":"892,008.00","shares_owned_after":148840.0,"shares_owned_after_display":"148,840","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-02-06","filed_date":"2026-02-09","scope":"insider"},{"id":8530681,"accession":"0000950170-23-064854","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-23-064854","line_url":"/filing/0000950170-23-064854#line-2","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"COLUMN GROUP GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; COLUMN GROUP L P; Column Group IV GP, LP; Column Group IV, LP; Column Group IV-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; TCG IV GP, LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5840.0,"shares_display":"5,840","price_per_share":0.6211,"price_display":"0.62","price_state":"stated","total_value":3627.224,"total_display":"3,627.22","shares_owned_after":949862.0,"shares_owned_after_display":"949,862","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-16","filed_date":"2023-11-17","scope":"insider"},{"id":8530677,"accession":"0000950170-23-064854","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-064854","line_url":"/filing/0000950170-23-064854#line-1","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"COLUMN GROUP GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; COLUMN GROUP L P; Column Group IV GP, LP; Column Group IV, LP; Column Group IV-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; TCG IV GP, LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16791.0,"shares_display":"16,791","price_per_share":0.7075,"price_display":"0.71","price_state":"stated","total_value":11879.6325,"total_display":"11,879.63","shares_owned_after":944022.0,"shares_owned_after_display":"944,022","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-15","filed_date":"2023-11-17","scope":"insider"},{"id":7987197,"accession":"0000899243-23-003137","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-003137","line_url":"/filing/0000899243-23-003137#line-2","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"Column Group Opportunity III, LP; Column Group IV GP, LP; COLUMN GROUP L P; COLUMN GROUP III-A, LP; COLUMN GROUP III, LP; Column Group IV-A, LP; COLUMN GROUP GP, LP; TCG IV GP, LLC; Column Group IV, LP; Column Group Opportunity III GP, LP","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":176730.0,"shares_display":"176,730","price_per_share":4.9986,"price_display":"5.00","price_state":"stated","total_value":883402.578,"total_display":"883,402.58","shares_owned_after":927231.0,"shares_owned_after_display":"927,231","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-31","filed_date":"2023-02-01","scope":"insider"},{"id":7987193,"accession":"0000899243-23-003137","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-003137","line_url":"/filing/0000899243-23-003137#line-1","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"Column Group Opportunity III, LP; Column Group IV GP, LP; COLUMN GROUP L P; COLUMN GROUP III-A, LP; COLUMN GROUP III, LP; Column Group IV-A, LP; COLUMN GROUP GP, LP; TCG IV GP, LLC; Column Group IV, LP; Column Group Opportunity III GP, LP","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7542.0,"shares_display":"7,542","price_per_share":4.9996,"price_display":"5.00","price_state":"stated","total_value":37706.9832,"total_display":"37,706.98","shares_owned_after":750501.0,"shares_owned_after_display":"750,501","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-30","filed_date":"2023-02-01","scope":"insider"},{"id":8350602,"accession":"0000899243-23-002637","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-002637","line_url":"/filing/0000899243-23-002637#line-1","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"COLUMN GROUP L P; Column Group IV GP, LP; Column Group Opportunity III, LP; COLUMN GROUP III, LP; Column Group IV-A, LP; Column Group IV, LP; Column Group Opportunity III GP, LP; COLUMN GROUP GP, LP; TCG IV GP, LLC; COLUMN GROUP III-A, LP","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9900.0,"shares_display":"9,900","price_per_share":4.9994,"price_display":"5.00","price_state":"stated","total_value":49494.06,"total_display":"49,494.06","shares_owned_after":742959.0,"shares_owned_after_display":"742,959","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-23","filed_date":"2023-01-25","scope":"insider"},{"id":8350589,"accession":"0000899243-23-002380","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-002380","line_url":"/filing/0000899243-23-002380#line-2","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"Column Group IV GP, LP; TCG IV GP, LLC; COLUMN GROUP GP, LP; Column Group IV, LP; Column Group Opportunity III, LP; COLUMN GROUP L P; COLUMN GROUP III, LP; Column Group IV-A, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":4.996,"price_display":"5.00","price_state":"stated","total_value":2498.0,"total_display":"2,498.00","shares_owned_after":733059.0,"shares_owned_after_display":"733,059","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-20","filed_date":"2023-01-23","scope":"insider"},{"id":8350582,"accession":"0000899243-23-002380","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-002380","line_url":"/filing/0000899243-23-002380#line-1","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"Column Group IV GP, LP; TCG IV GP, LLC; COLUMN GROUP GP, LP; Column Group IV, LP; Column Group Opportunity III, LP; COLUMN GROUP L P; COLUMN GROUP III, LP; Column Group IV-A, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":37639.0,"shares_display":"37,639","price_per_share":4.9976,"price_display":"5.00","price_state":"stated","total_value":188104.6664,"total_display":"188,104.67","shares_owned_after":732559.0,"shares_owned_after_display":"732,559","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-19","filed_date":"2023-01-23","scope":"insider"},{"id":8062095,"accession":"0000899243-23-001855","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-001855","line_url":"/filing/0000899243-23-001855#line-1","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"COLUMN GROUP L P; Column Group Opportunity III, LP; COLUMN GROUP III, LP; Column Group IV-A, LP; Column Group Opportunity III GP, LP; Column Group IV GP, LP; COLUMN GROUP GP, LP; TCG IV GP, LLC; Column Group IV, LP; COLUMN GROUP III-A, LP","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5378.0,"shares_display":"5,378","price_per_share":4.9466,"price_display":"4.95","price_state":"stated","total_value":26602.8148,"total_display":"26,602.81","shares_owned_after":694920.0,"shares_owned_after_display":"694,920","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-12","filed_date":"2023-01-17","scope":"insider"},{"id":8720417,"accession":"0000899243-23-001695","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-001695","line_url":"/filing/0000899243-23-001695#line-2","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"Column Group IV GP, LP; TCG IV GP, LLC; COLUMN GROUP GP, LP; Column Group Opportunity III, LP; COLUMN GROUP L P; COLUMN GROUP III, LP; Column Group IV-A, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group IV, LP","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":209000.0,"shares_display":"209,000","price_per_share":4.76,"price_display":"4.76","price_state":"stated","total_value":994840.0,"total_display":"994,840.00","shares_owned_after":689542.0,"shares_owned_after_display":"689,542","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-11","filed_date":"2023-01-12","scope":"insider"},{"id":8720414,"accession":"0000899243-23-001695","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-001695","line_url":"/filing/0000899243-23-001695#line-1","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"Column Group IV GP, LP; TCG IV GP, LLC; COLUMN GROUP GP, LP; Column Group Opportunity III, LP; COLUMN GROUP L P; COLUMN GROUP III, LP; Column Group IV-A, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group IV, LP","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100070.0,"shares_display":"100,070","price_per_share":4.8418,"price_display":"4.84","price_state":"stated","total_value":484518.926,"total_display":"484,518.93","shares_owned_after":480542.0,"shares_owned_after_display":"480,542","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-10","filed_date":"2023-01-12","scope":"insider"},{"id":6444408,"accession":"0000899243-22-038466","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-038466","line_url":"/filing/0000899243-22-038466#line-1","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; Column Group IV GP, LP; COLUMN GROUP L P; COLUMN GROUP III-A, LP; COLUMN GROUP GP, LP; Column Group IV, LP; COLUMN GROUP III, LP; Column Group IV-A, LP; TCG IV GP, LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300.0,"shares_display":"300","price_per_share":4.9767,"price_display":"4.98","price_state":"stated","total_value":1493.01,"total_display":"1,493.01","shares_owned_after":380472.0,"shares_owned_after_display":"380,472","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-12","filed_date":"2022-12-14","scope":"insider"},{"id":6444318,"accession":"0000899243-22-036916","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-036916","line_url":"/filing/0000899243-22-036916#line-2","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"COLUMN GROUP III-A, LP; TCG IV GP, LLC; COLUMN GROUP GP, LP; COLUMN GROUP III, LP; Column Group IV-A, LP; COLUMN GROUP L P; Column Group IV GP, LP; Column Group Opportunity III, LP; Column Group IV, LP; Column Group Opportunity III GP, LP","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4330.0,"shares_display":"4,330","price_per_share":4.9991,"price_display":"5.00","price_state":"stated","total_value":21646.103,"total_display":"21,646.10","shares_owned_after":380172.0,"shares_owned_after_display":"380,172","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-22","filed_date":"2022-11-23","scope":"insider"},{"id":6444315,"accession":"0000899243-22-036916","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-036916","line_url":"/filing/0000899243-22-036916#line-1","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"COLUMN GROUP III-A, LP; TCG IV GP, LLC; COLUMN GROUP GP, LP; COLUMN GROUP III, LP; Column Group IV-A, LP; COLUMN GROUP L P; Column Group IV GP, LP; Column Group Opportunity III, LP; Column Group IV, LP; Column Group Opportunity III GP, LP","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":35997.0,"shares_display":"35,997","price_per_share":4.9988,"price_display":"5.00","price_state":"stated","total_value":179941.8036,"total_display":"179,941.80","shares_owned_after":375842.0,"shares_owned_after_display":"375,842","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-21","filed_date":"2022-11-23","scope":"insider"},{"id":6342383,"accession":"0000899243-22-035277","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-035277","line_url":"/filing/0000899243-22-035277#line-2","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"Column Group Opportunity III GP, LP; Column Group IV, LP; COLUMN GROUP III-A, LP; Column Group IV GP, LP; TCG IV GP, LLC; COLUMN GROUP GP, LP; Column Group Opportunity III, LP; COLUMN GROUP L P; COLUMN GROUP III, LP; Column Group IV-A, LP","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":35058.0,"shares_display":"35,058","price_per_share":4.7156,"price_display":"4.72","price_state":"stated","total_value":165319.5048,"total_display":"165,319.50","shares_owned_after":339845.0,"shares_owned_after_display":"339,845","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-04","filed_date":"2022-11-07","scope":"insider"},{"id":6342379,"accession":"0000899243-22-035277","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-035277","line_url":"/filing/0000899243-22-035277#line-1","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"Column Group Opportunity III GP, LP; Column Group IV, LP; COLUMN GROUP III-A, LP; Column Group IV GP, LP; TCG IV GP, LLC; COLUMN GROUP GP, LP; Column Group Opportunity III, LP; COLUMN GROUP L P; COLUMN GROUP III, LP; Column Group IV-A, LP","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":104090.0,"shares_display":"104,090","price_per_share":4.9871,"price_display":"4.99","price_state":"stated","total_value":519107.239,"total_display":"519,107.24","shares_owned_after":304787.0,"shares_owned_after_display":"304,787","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-03","filed_date":"2022-11-07","scope":"insider"},{"id":6945351,"accession":"0000899243-22-034562","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-034562","line_url":"/filing/0000899243-22-034562#line-1","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"TCG IV GP, LLC; COLUMN GROUP L P; Column Group IV GP, LP; Column Group Opportunity III, LP; Column Group IV, LP; COLUMN GROUP GP, LP; COLUMN GROUP III-A, LP; COLUMN GROUP III, LP; Column Group IV-A, LP; Column Group Opportunity III GP, LP","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":76877.0,"shares_display":"76,877","price_per_share":4.8602,"price_display":"4.86","price_state":"stated","total_value":373637.5954,"total_display":"373,637.60","shares_owned_after":200697.0,"shares_owned_after_display":"200,697","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-27","filed_date":"2022-10-31","scope":"insider"},{"id":6741950,"accession":"0000899243-22-034359","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-034359","line_url":"/filing/0000899243-22-034359#line-2","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"COLUMN GROUP III-A, LP; COLUMN GROUP III, LP; Column Group IV-A, LP; Column Group Opportunity III GP, LP; TCG IV GP, LLC; COLUMN GROUP GP, LP; Column Group IV, LP; Column Group IV GP, LP; COLUMN GROUP L P; Column Group Opportunity III, LP","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":72774.0,"shares_display":"72,774","price_per_share":4.8512,"price_display":"4.85","price_state":"stated","total_value":353041.2288,"total_display":"353,041.23","shares_owned_after":123820.0,"shares_owned_after_display":"123,820","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-26","filed_date":"2022-10-27","scope":"insider"},{"id":6741947,"accession":"0000899243-22-034359","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-034359","line_url":"/filing/0000899243-22-034359#line-1","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"COLUMN GROUP III-A, LP; COLUMN GROUP III, LP; Column Group IV-A, LP; Column Group Opportunity III GP, LP; TCG IV GP, LLC; COLUMN GROUP GP, LP; Column Group IV, LP; Column Group IV GP, LP; COLUMN GROUP L P; Column Group Opportunity III, LP","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":51046.0,"shares_display":"51,046","price_per_share":4.7484,"price_display":"4.75","price_state":"stated","total_value":242386.8264,"total_display":"242,386.83","shares_owned_after":51046.0,"shares_owned_after_display":"51,046","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-25","filed_date":"2022-10-27","scope":"insider"},{"id":6089396,"accession":"0000899243-22-022214","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-022214","line_url":"/filing/0000899243-22-022214#line-2","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"COLUMN GROUP III, LP; Column Group IV-A, LP; Column Group IV, LP; TCG IV GP, LLC; Column Group IV GP, LP; COLUMN GROUP GP, LP; COLUMN GROUP III-A, LP; COLUMN GROUP L P","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":951684.0,"shares_display":"951,684","price_per_share":13.5,"price_display":"13.50","price_state":"stated","total_value":12847734.0,"total_display":"12,847,734.00","shares_owned_after":2650177.0,"shares_owned_after_display":"2,650,177","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-06-09","filed_date":"2022-06-13","scope":"insider"},{"id":6089393,"accession":"0000899243-22-022214","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-022214","line_url":"/filing/0000899243-22-022214#line-1","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"COLUMN GROUP III, LP; Column Group IV-A, LP; Column Group IV, LP; TCG IV GP, LLC; Column Group IV GP, LP; COLUMN GROUP GP, LP; COLUMN GROUP III-A, LP; COLUMN GROUP L P","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":32477.0,"shares_display":"32,477","price_per_share":13.5,"price_display":"13.50","price_state":"stated","total_value":438439.5,"total_display":"438,439.50","shares_owned_after":90442.0,"shares_owned_after_display":"90,442","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-06-09","filed_date":"2022-06-13","scope":"insider"},{"id":6714216,"accession":"0000899243-22-021216","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-021216","line_url":"/filing/0000899243-22-021216#line-2","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"COLUMN GROUP III-A, LP; Column Group IV GP, LP; Column Group IV, LP; COLUMN GROUP L P; TCG IV GP, LLC; COLUMN GROUP GP, LP; COLUMN GROUP III, LP; Column Group IV-A, LP","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":33071.0,"shares_display":"33,071","price_per_share":13.0333,"price_display":"13.03","price_state":"stated","total_value":431024.2643,"total_display":"431,024.26","shares_owned_after":1698493.0,"shares_owned_after_display":"1,698,493","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-06-02","filed_date":"2022-06-06","scope":"insider"},{"id":6714211,"accession":"0000899243-22-021216","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-021216","line_url":"/filing/0000899243-22-021216#line-1","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"COLUMN GROUP III-A, LP; Column Group IV GP, LP; Column Group IV, LP; COLUMN GROUP L P; TCG IV GP, LLC; COLUMN GROUP GP, LP; COLUMN GROUP III, LP; Column Group IV-A, LP","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1129.0,"shares_display":"1,129","price_per_share":13.0333,"price_display":"13.03","price_state":"stated","total_value":14714.5957,"total_display":"14,714.60","shares_owned_after":57965.0,"shares_owned_after_display":"57,965","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-06-02","filed_date":"2022-06-06","scope":"insider"},{"id":6841021,"accession":"0000899243-22-020690","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-020690","line_url":"/filing/0000899243-22-020690#line-4","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"COLUMN GROUP GP, LP; COLUMN GROUP L P; COLUMN GROUP III-A, LP; Column Group IV GP, LP; Column Group IV, LP; COLUMN GROUP III, LP; Column Group IV-A, LP; TCG IV GP, LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":88964.0,"shares_display":"88,964","price_per_share":13.45,"price_display":"13.45","price_state":"stated","total_value":1196565.8,"total_display":"1,196,565.80","shares_owned_after":1665422.0,"shares_owned_after_display":"1,665,422","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-06-01","filed_date":"2022-06-02","scope":"insider"},{"id":6841017,"accession":"0000899243-22-020690","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-020690","line_url":"/filing/0000899243-22-020690#line-3","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"COLUMN GROUP GP, LP; COLUMN GROUP L P; COLUMN GROUP III-A, LP; Column Group IV GP, LP; Column Group IV, LP; COLUMN GROUP III, LP; Column Group IV-A, LP; TCG IV GP, LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3036.0,"shares_display":"3,036","price_per_share":13.45,"price_display":"13.45","price_state":"stated","total_value":40834.2,"total_display":"40,834.20","shares_owned_after":56836.0,"shares_owned_after_display":"56,836","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-06-01","filed_date":"2022-06-02","scope":"insider"},{"id":6841012,"accession":"0000899243-22-020690","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-020690","line_url":"/filing/0000899243-22-020690#line-2","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"COLUMN GROUP GP, LP; COLUMN GROUP L P; COLUMN GROUP III-A, LP; Column Group IV GP, LP; Column Group IV, LP; COLUMN GROUP III, LP; Column Group IV-A, LP; TCG IV GP, LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":59766.0,"shares_display":"59,766","price_per_share":13.4658,"price_display":"13.47","price_state":"stated","total_value":804797.0028,"total_display":"804,797.00","shares_owned_after":1576458.0,"shares_owned_after_display":"1,576,458","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-31","filed_date":"2022-06-02","scope":"insider"},{"id":6841007,"accession":"0000899243-22-020690","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-020690","line_url":"/filing/0000899243-22-020690#line-1","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"COLUMN GROUP GP, LP; COLUMN GROUP L P; COLUMN GROUP III-A, LP; Column Group IV GP, LP; Column Group IV, LP; COLUMN GROUP III, LP; Column Group IV-A, LP; TCG IV GP, LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2040.0,"shares_display":"2,040","price_per_share":13.4658,"price_display":"13.47","price_state":"stated","total_value":27470.232,"total_display":"27,470.23","shares_owned_after":53800.0,"shares_owned_after_display":"53,800","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-31","filed_date":"2022-06-02","scope":"insider"},{"id":6691316,"accession":"0000899243-22-020203","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-020203","line_url":"/filing/0000899243-22-020203#line-4","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"COLUMN GROUP III, LP; Column Group IV-A, LP; COLUMN GROUP III-A, LP; TCG IV GP, LLC; Column Group IV GP, LP; COLUMN GROUP GP, LP; Column Group IV, LP; COLUMN GROUP L P","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2621.0,"shares_display":"2,621","price_per_share":13.4513,"price_display":"13.45","price_state":"stated","total_value":35255.8573,"total_display":"35,255.86","shares_owned_after":1516692.0,"shares_owned_after_display":"1,516,692","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-27","filed_date":"2022-05-31","scope":"insider"},{"id":6691314,"accession":"0000899243-22-020203","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-020203","line_url":"/filing/0000899243-22-020203#line-3","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"COLUMN GROUP III, LP; Column Group IV-A, LP; COLUMN GROUP III-A, LP; TCG IV GP, LLC; Column Group IV GP, LP; COLUMN GROUP GP, LP; Column Group IV, LP; COLUMN GROUP L P","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":89.0,"shares_display":"89","price_per_share":13.4513,"price_display":"13.45","price_state":"stated","total_value":1197.1657,"total_display":"1,197.17","shares_owned_after":51760.0,"shares_owned_after_display":"51,760","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-27","filed_date":"2022-05-31","scope":"insider"},{"id":6691312,"accession":"0000899243-22-020203","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-020203","line_url":"/filing/0000899243-22-020203#line-2","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"COLUMN GROUP III, LP; Column Group IV-A, LP; COLUMN GROUP III-A, LP; TCG IV GP, LLC; Column Group IV GP, LP; COLUMN GROUP GP, LP; Column Group IV, LP; COLUMN GROUP L P","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":19534.0,"shares_display":"19,534","price_per_share":13.4935,"price_display":"13.49","price_state":"stated","total_value":263582.029,"total_display":"263,582.03","shares_owned_after":1514071.0,"shares_owned_after_display":"1,514,071","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-26","filed_date":"2022-05-31","scope":"insider"},{"id":6691310,"accession":"0000899243-22-020203","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-020203","line_url":"/filing/0000899243-22-020203#line-1","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"COLUMN GROUP III, LP; Column Group IV-A, LP; COLUMN GROUP III-A, LP; TCG IV GP, LLC; Column Group IV GP, LP; COLUMN GROUP GP, LP; Column Group IV, LP; COLUMN GROUP L P","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":667.0,"shares_display":"667","price_per_share":13.4935,"price_display":"13.49","price_state":"stated","total_value":9000.1645,"total_display":"9,000.16","shares_owned_after":51671.0,"shares_owned_after_display":"51,671","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-26","filed_date":"2022-05-31","scope":"insider"},{"id":6532666,"accession":"0000899243-22-019940","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-019940","line_url":"/filing/0000899243-22-019940#line-2","is_derivative":false,"issuer_cik":"0001600420","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001600420","owner_cik":null,"owner_name":"Column Group IV-A, LP; Column Group IV, LP; Column Group IV GP, LP; TCG IV GP, LLC; COLUMN GROUP II, LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1837.0,"shares_display":"1,837","price_per_share":12.4549,"price_display":"12.45","price_state":"stated","total_value":22879.6513,"total_display":"22,879.65","shares_owned_after":1236261.0,"shares_owned_after_display":"1,236,261","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-25","filed_date":"2022-05-27","scope":"insider"},{"id":6532662,"accession":"0000899243-22-019940","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-019940","line_url":"/filing/0000899243-22-019940#line-1","is_derivative":false,"issuer_cik":"0001600420","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001600420","owner_cik":null,"owner_name":"Column Group IV-A, LP; Column Group IV, LP; Column Group IV GP, LP; TCG IV GP, LLC; COLUMN GROUP II, LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":63.0,"shares_display":"63","price_per_share":12.4549,"price_display":"12.45","price_state":"stated","total_value":784.6587,"total_display":"784.66","shares_owned_after":42189.0,"shares_owned_after_display":"42,189","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-25","filed_date":"2022-05-27","scope":"insider"},{"id":6318493,"accession":"0000899243-22-019690","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-019690","line_url":"/filing/0000899243-22-019690#line-4","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"COLUMN GROUP III, LP; Column Group IV-A, LP; COLUMN GROUP III-A, LP; Column Group IV, LP; COLUMN GROUP L P; Column Group IV GP, LP; TCG IV GP, LLC; COLUMN GROUP GP, LP","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":41863.0,"shares_display":"41,863","price_per_share":13.4349,"price_display":"13.43","price_state":"stated","total_value":562425.2187,"total_display":"562,425.22","shares_owned_after":1494537.0,"shares_owned_after_display":"1,494,537","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-25","filed_date":"2022-05-26","scope":"insider"},{"id":6318489,"accession":"0000899243-22-019690","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-019690","line_url":"/filing/0000899243-22-019690#line-3","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"COLUMN GROUP III, LP; Column Group IV-A, LP; COLUMN GROUP III-A, LP; Column Group IV, LP; COLUMN GROUP L P; Column Group IV GP, LP; TCG IV GP, LLC; COLUMN GROUP GP, LP","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1429.0,"shares_display":"1,429","price_per_share":13.4349,"price_display":"13.43","price_state":"stated","total_value":19198.4721,"total_display":"19,198.47","shares_owned_after":51004.0,"shares_owned_after_display":"51,004","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-25","filed_date":"2022-05-26","scope":"insider"},{"id":6318486,"accession":"0000899243-22-019690","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-019690","line_url":"/filing/0000899243-22-019690#line-2","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"COLUMN GROUP III, LP; Column Group IV-A, LP; COLUMN GROUP III-A, LP; Column Group IV, LP; COLUMN GROUP L P; Column Group IV GP, LP; TCG IV GP, LLC; COLUMN GROUP GP, LP","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":17240.0,"shares_display":"17,240","price_per_share":13.368,"price_display":"13.37","price_state":"stated","total_value":230464.32,"total_display":"230,464.32","shares_owned_after":1452674.0,"shares_owned_after_display":"1,452,674","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-24","filed_date":"2022-05-26","scope":"insider"},{"id":6318483,"accession":"0000899243-22-019690","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-019690","line_url":"/filing/0000899243-22-019690#line-1","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"COLUMN GROUP III, LP; Column Group IV-A, LP; COLUMN GROUP III-A, LP; Column Group IV, LP; COLUMN GROUP L P; Column Group IV GP, LP; TCG IV GP, LLC; COLUMN GROUP GP, LP","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":588.0,"shares_display":"588","price_per_share":13.368,"price_display":"13.37","price_state":"stated","total_value":7860.384,"total_display":"7,860.38","shares_owned_after":49575.0,"shares_owned_after_display":"49,575","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-24","filed_date":"2022-05-26","scope":"insider"},{"id":6235738,"accession":"0000899243-22-019471","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-019471","line_url":"/filing/0000899243-22-019471#line-4","is_derivative":false,"issuer_cik":"0001600420","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001600420","owner_cik":null,"owner_name":"Column Group IV, LP; Column Group IV-A, LP; Column Group IV GP, LP; TCG IV GP, LLC; COLUMN GROUP II, LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15776.0,"shares_display":"15,776","price_per_share":12.0021,"price_display":"12.00","price_state":"stated","total_value":189345.1296,"total_display":"189,345.13","shares_owned_after":1234424.0,"shares_owned_after_display":"1,234,424","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-24","filed_date":"2022-05-25","scope":"insider"},{"id":6235730,"accession":"0000899243-22-019471","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-019471","line_url":"/filing/0000899243-22-019471#line-3","is_derivative":false,"issuer_cik":"0001600420","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001600420","owner_cik":null,"owner_name":"Column Group IV, LP; Column Group IV-A, LP; Column Group IV GP, LP; TCG IV GP, LLC; COLUMN GROUP II, LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":538.0,"shares_display":"538","price_per_share":12.0021,"price_display":"12.00","price_state":"stated","total_value":6457.1298,"total_display":"6,457.13","shares_owned_after":42126.0,"shares_owned_after_display":"42,126","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-24","filed_date":"2022-05-25","scope":"insider"},{"id":6235725,"accession":"0000899243-22-019471","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-019471","line_url":"/filing/0000899243-22-019471#line-2","is_derivative":false,"issuer_cik":"0001600420","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001600420","owner_cik":null,"owner_name":"Column Group IV, LP; Column Group IV-A, LP; Column Group IV GP, LP; TCG IV GP, LLC; COLUMN GROUP II, LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9898.0,"shares_display":"9,898","price_per_share":12.4993,"price_display":"12.50","price_state":"stated","total_value":123718.0714,"total_display":"123,718.07","shares_owned_after":1218648.0,"shares_owned_after_display":"1,218,648","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-23","filed_date":"2022-05-25","scope":"insider"},{"id":6235724,"accession":"0000899243-22-019471","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-019471","line_url":"/filing/0000899243-22-019471#line-1","is_derivative":false,"issuer_cik":"0001600420","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001600420","owner_cik":null,"owner_name":"Column Group IV, LP; Column Group IV-A, LP; Column Group IV GP, LP; TCG IV GP, LLC; COLUMN GROUP II, LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":338.0,"shares_display":"338","price_per_share":12.4993,"price_display":"12.50","price_state":"stated","total_value":4224.7634,"total_display":"4,224.76","shares_owned_after":41588.0,"shares_owned_after_display":"41,588","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-23","filed_date":"2022-05-25","scope":"insider"},{"id":6670156,"accession":"0000899243-22-019209","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-019209","line_url":"/filing/0000899243-22-019209#line-4","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"TCG IV GP, LLC; COLUMN GROUP III, LP; Column Group IV-A, LP; Column Group IV, LP; COLUMN GROUP L P; COLUMN GROUP III-A, LP; COLUMN GROUP GP, LP; Column Group IV GP, LP","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":18406.0,"shares_display":"18,406","price_per_share":13.4776,"price_display":"13.48","price_state":"stated","total_value":248068.7056,"total_display":"248,068.71","shares_owned_after":1435434.0,"shares_owned_after_display":"1,435,434","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-20","filed_date":"2022-05-23","scope":"insider"},{"id":6670154,"accession":"0000899243-22-019209","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-019209","line_url":"/filing/0000899243-22-019209#line-3","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"TCG IV GP, LLC; COLUMN GROUP III, LP; Column Group IV-A, LP; Column Group IV, LP; COLUMN GROUP L P; COLUMN GROUP III-A, LP; COLUMN GROUP GP, LP; Column Group IV GP, LP","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":628.0,"shares_display":"628","price_per_share":13.4776,"price_display":"13.48","price_state":"stated","total_value":8463.9328,"total_display":"8,463.93","shares_owned_after":48987.0,"shares_owned_after_display":"48,987","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-20","filed_date":"2022-05-23","scope":"insider"},{"id":6670153,"accession":"0000899243-22-019209","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-019209","line_url":"/filing/0000899243-22-019209#line-2","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"TCG IV GP, LLC; COLUMN GROUP III, LP; Column Group IV-A, LP; Column Group IV, LP; COLUMN GROUP L P; COLUMN GROUP III-A, LP; COLUMN GROUP GP, LP; Column Group IV GP, LP","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":19984.0,"shares_display":"19,984","price_per_share":13.2547,"price_display":"13.25","price_state":"stated","total_value":264881.9248,"total_display":"264,881.92","shares_owned_after":1417028.0,"shares_owned_after_display":"1,417,028","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-19","filed_date":"2022-05-23","scope":"insider"},{"id":6670151,"accession":"0000899243-22-019209","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-019209","line_url":"/filing/0000899243-22-019209#line-1","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"TCG IV GP, LLC; COLUMN GROUP III, LP; Column Group IV-A, LP; Column Group IV, LP; COLUMN GROUP L P; COLUMN GROUP III-A, LP; COLUMN GROUP GP, LP; Column Group IV GP, LP","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":682.0,"shares_display":"682","price_per_share":13.2547,"price_display":"13.25","price_state":"stated","total_value":9039.7054,"total_display":"9,039.71","shares_owned_after":48359.0,"shares_owned_after_display":"48,359","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-19","filed_date":"2022-05-23","scope":"insider"},{"id":6341701,"accession":"0000899243-22-018849","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-018849","line_url":"/filing/0000899243-22-018849#line-4","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"TCG IV GP, LLC; COLUMN GROUP GP, LP; COLUMN GROUP III, LP; Column Group IV-A, LP; Column Group IV, LP; COLUMN GROUP L P; COLUMN GROUP III-A, LP; Column Group IV GP, LP","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":60583.0,"shares_display":"60,583","price_per_share":13.2039,"price_display":"13.20","price_state":"stated","total_value":799931.8737,"total_display":"799,931.87","shares_owned_after":1397044.0,"shares_owned_after_display":"1,397,044","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-18","filed_date":"2022-05-19","scope":"insider"},{"id":6341698,"accession":"0000899243-22-018849","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-018849","line_url":"/filing/0000899243-22-018849#line-3","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"TCG IV GP, LLC; COLUMN GROUP GP, LP; COLUMN GROUP III, LP; Column Group IV-A, LP; Column Group IV, LP; COLUMN GROUP L P; COLUMN GROUP III-A, LP; Column Group IV GP, LP","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2067.0,"shares_display":"2,067","price_per_share":13.2039,"price_display":"13.20","price_state":"stated","total_value":27292.4613,"total_display":"27,292.46","shares_owned_after":47677.0,"shares_owned_after_display":"47,677","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-18","filed_date":"2022-05-19","scope":"insider"},{"id":6341694,"accession":"0000899243-22-018849","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-018849","line_url":"/filing/0000899243-22-018849#line-2","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"TCG IV GP, LLC; COLUMN GROUP GP, LP; COLUMN GROUP III, LP; Column Group IV-A, LP; Column Group IV, LP; COLUMN GROUP L P; COLUMN GROUP III-A, LP; Column Group IV GP, LP","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":86110.0,"shares_display":"86,110","price_per_share":13.4171,"price_display":"13.42","price_state":"stated","total_value":1155346.481,"total_display":"1,155,346.48","shares_owned_after":1336461.0,"shares_owned_after_display":"1,336,461","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-17","filed_date":"2022-05-19","scope":"insider"}],"next_cursor":"2022-05-17|6341694","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001861123","name":"Eikon Therapeutics, Inc.","url":"/issuer/0001861123","role":"Ten percent owner","n_filings":1,"first_seen":"2026-02-09","last_seen":"2026-02-09"},{"type":"issuer","type_label":"ISSUER","cik":"0001426332","name":"NGM BIOPHARMACEUTICALS INC","url":"/issuer/0001426332","role":"Ten percent owner","n_filings":22,"first_seen":"2022-01-26","last_seen":"2023-11-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001673772","name":"RAPT Therapeutics, Inc.","url":"/issuer/0001673772","role":"Ten percent owner","n_filings":3,"first_seen":"2022-05-12","last_seen":"2022-05-27"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001796356","retrieved_at":"2026-08-21T21:55:30+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}